Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M141,498Revenue $M11,202Net Margin (%)45.5Z-Score8.5
Enterprise Value $M144,889EPS $1.8Operating Margin %58.6F-Score8
P/E(ttm))16.6Cash Flow Per Share $4.3Pre-tax Margin (%)56.7Higher ROA y-yY
Price/Book10.510-y EBITDA Growth Rate %0Quick Ratio1.8Cash flow > EarningsY
Price/Sales7.65-y EBITDA Growth Rate %8.2Current Ratio2.1Lower Leverage y-yN
Price/Cash Flow17.4y-y EBITDA Growth Rate %176ROA % (ttm)35.3Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)72.0Less Shares Outstanding y-yY
Payout Ratio %0Shares Outstanding M1,509ROI % (ttm)15.0Gross Margin Increase y-yY

Gurus Latest Trades with GILD

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
GILDRonald Muhlenkamp 2014-09-30 Add1.19%$85.07 - $109.43
($97.98)
$ 93.79-4%Add 42.59%206,350
GILDJoel Greenblatt 2014-09-30 Add0.21%$85.07 - $109.43
($97.98)
$ 93.79-4%Add 42.28%664,223
GILDDavid Dreman 2014-09-30 Buy 0.02%$85.07 - $109.43
($97.98)
$ 93.79-4%New holding, 2388 sh.2,388
GILDJohn Burbank 2014-09-30 Add0.01%$85.07 - $109.43
($97.98)
$ 93.79-4%Add 219.9%12,073
GILDDodge & Cox 2014-09-30 Buy $85.07 - $109.43
($97.98)
$ 93.79-4%New holding, 4800 sh.4,800
GILDKen Heebner 2014-09-30 Reduce-0.33%$85.07 - $109.43
($97.98)
$ 93.79-4%Reduce -8.77%1,560,000
GILDVanguard Health Care Fund 2014-09-30 Reduce-0.28%$85.07 - $109.43
($97.98)
$ 93.79-4%Reduce -76.79%379,200
GILDRay Dalio 2014-09-30 Reduce-0.07%$85.07 - $109.43
($97.98)
$ 93.79-4%Reduce -30.96%241,521
GILDKen Fisher 2014-09-30 Reduce-0.04%$85.07 - $109.43
($97.98)
$ 93.79-4%Reduce -21.74%763,423
GILDKen Heebner 2014-06-30 Buy 3.8%$65.48 - $83.02
($77.76)
$ 93.7921%New holding, 1710000 sh.1,710,000
GILDJulian Robertson 2014-06-30 Add2.98%$65.48 - $83.02
($77.76)
$ 93.7921%Add 28.55%443,911
GILDJoel Greenblatt 2014-06-30 Buy 0.48%$65.48 - $83.02
($77.76)
$ 93.7921%New holding, 466853 sh.466,853
GILDJohn Rogers 2014-06-30 Add0.25%$65.48 - $83.02
($77.76)
$ 93.7921%Add 60.78%638,734
GILDKen Fisher 2014-06-30 Add0.07%$65.48 - $83.02
($77.76)
$ 93.7921%Add 62.11%975,483
GILDRay Dalio 2014-06-30 Add0.06%$65.48 - $83.02
($77.76)
$ 93.7921%Add 41.22%349,821
GILDRonald Muhlenkamp 2014-06-30 Reduce-0.59%$65.48 - $83.02
($77.76)
$ 93.7921%Reduce -24.63%144,715
GILDVanguard Health Care Fund 2014-06-30 Reduce-0.21%$65.48 - $83.02
($77.76)
$ 93.7921%Reduce -39.79%1,633,700
GILDGeorge Soros 2014-06-30 Sold Out -0.04%$65.48 - $83.02
($77.76)
$ 93.7921%Sold Out0
GILDMariko Gordon 2014-06-30 Reduce-0.02%$65.48 - $83.02
($77.76)
$ 93.7921%Reduce -35.57%11,654
GILDJulian Robertson 2014-03-31 Add0.59%$68.55 - $83.95
($78.44)
$ 93.7920%Add 7.91%345,320
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

GILD is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
GILD David Dreman 2014-09-302,38800.02New Buy
GILD Dodge & Cox 2014-09-304,80000New Buy
GILD John Burbank 2014-09-3012,07300.02+219.9%
GILD Ronald Muhlenkamp 2014-09-30206,3500.014+42.59%
GILD Joel Greenblatt 2014-09-30664,2230.040.7+42.28%
GILD John Rogers 2014-09-30643,8960.040.88+0.81%
GILD Julian Robertson 2014-09-30443,9110.0312.5
GILD Jean-Marie Eveillard 2014-09-3040000
GILD Ken Heebner 2014-09-301,560,0000.14.7-8.77%
GILD Mariko Gordon 2014-09-3010,36600.05-11.05%
GILD Mario Gabelli 2014-09-3042,60000.02-13.36%
GILD Ken Fisher 2014-09-30763,4230.050.17-21.74%
GILD Ray Dalio 2014-09-30241,5210.020.2-30.96%
GILD Vanguard Health Care Fund 2014-09-30379,2000.030.1-76.79%
Premium Most recent portfolio changes are included for Premium Members only!


GILD: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Cogan John FrancisDirector 2014-12-22Sell26,000$95.03-3.94view
MILLIGAN JOHN FPresident and COO 2014-12-08Sell146,823$106.26-14.09view
Whitley Richard JamesDirector 2014-12-01Sell5,000$100.19-8.88view
Carter Paul RutherfordEVP Commercial Ops 2014-12-01Sell2,000$100.02-8.73view
Alton Gregg HEVP, Corp & Med Affairs 2014-12-01Sell33,000$100.79-9.43view
MARTIN JOHN CChairman and CEO 2014-12-01Sell140,633$100.72-9.36view
Cogan John FrancisDirector 2014-11-21Sell25,000$101.23-9.82view
MILLIGAN JOHN FPresident and COO 2014-11-07Sell146,895$107.37-14.98view
Whitley Richard JamesDirector 2014-11-03Sell5,000$112.02-18.51view
MARTIN JOHN CChairman and CEO 2014-11-03Sell140,625$110.4-17.31view

Press Releases about GILD :

Quarterly/Annual Reports about GILD:

News about GILD:

Articles On GuruFocus.com
Express Scripts Knocks Gilead’s Hepatitis C Drug in Favor of AbbVie Dec 22 2014 
Is it Time to Sell Gilead Sciences? Dec 18 2014 
Druckenmiller Adds Healthcare Stocks to Portfolio Dec 15 2014 
Weekly CFO Sells Highlight: Coco-Cola Co, Gilead Sciences Inc, AutoZone Inc. Dec 14 2014 
Weekly Insider Sells Highlight: WAT, KO, GILD, AZO, MAS Dec 14 2014 
T Rowe Price's Top Stakes for the Third Quarter Dec 09 2014 
3 Strong Buys and Sells Dec 08 2014 
Gilead Sciences' Recent Plunge Makes It One of The Hot Stocks To Buy Dec 01 2014 
now Nov 29 2014 
Weekly CFO Sells Highlight: Tableau Software Inc, Gilead Sciences Inc, Facebook Inc. Nov 16 2014 


More From Other Websites
Gilead regains ground after selloff triggered by pricey hepatitis C drug Dec 24 2014
U.S. equity markets end mostly higher on this abbreviated trading session Dec 24 2014
Market Closes Half Session Mixed; Airline Stocks Soar Dec 24 2014
Stocks Score Small Gains; Virgin America Takes Flight Dec 24 2014
How Gilead And Johnson & Johnson's Tumble Could've Burned These Hedge Funds Dec 24 2014
AQR Capital raises position in Gilead Sciences Dec 24 2014
Stocks Jump Into Short Session; Virgin America Soars On Ratings Dec 24 2014
Tuesday’s Notable Options Activity: Bio Hazzard Dec 24 2014
Off the Charts: Biotech breakdown Dec 23 2014
Buy biotech dip? Dec 23 2014
3 Charts That Show Why There's Gilead Sciences...And Then There's Everybody Else Dec 23 2014
Dow Closes At Record High; Rest Of Market Mixed Dec 23 2014
Hepatitis C drug wars Dec 23 2014
Gilead Sciences Plunges for Second Day in a Row: What Wall Street's Saying Dec 23 2014
Analysts Predict Big Value Trap for Gilead Investors Dec 23 2014
Gilead Sciences Is Not a Buy; It's Heading Lower on Price War: Jim Cramer Dec 23 2014
Deutsche Bank Analyst Sees Gilead Sciences Vs. AbbVie 'Price War' Dec 23 2014
Cramer's Mad Dash: Wait on Gilead Dec 23 2014
US STOCKS-Futures edge up after latest record; data on tap Dec 23 2014
US STOCKS-Futures edge up after latest record; data on tap Dec 23 2014

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK